A carregar...
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
AIM: To assess the toxicity, tolerance, steroid-sparing capacity, effectiveness, and response rate to imatinib and dasatinib for the treatment of severe sclerotic chronic graft-vs-host disease (scGVHD). METHODS: This retrospective study analyzed 8 consecutive patients with severe refractory scGVHD w...
Na minha lista:
| Publicado no: | Croat Med J |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Croatian Medical Schools
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937227/ https://ncbi.nlm.nih.gov/pubmed/27374826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2016.57.247 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|